Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 26, 2007
Cost-effectiveness of grass allergen tablet (GRAZAX) for the prevention of seasonal grass pollen induced rhinoconjunctivitis - a Northern European perspectiveC Bachert, U Vestenbaek, J Christensen, et al.
Health Policy and Planning|July 8, 2011
National decision-making on adopting new vaccines: a systematic reviewH E D Burchett, S Mounier-Jack, U K Griffiths, et al.
Vaccine|February 8, 2014
Costs of vaccine delivery in the Gambia before and after, pentavalent and pneumococcal conjugate vaccine introductionsE Usuf, G Mackenzie, Y Lowe-Jallow, et al.
Vaccine|September 25, 2003
The cost of measles in industrialised countriesH Carabin, W J Edmunds, M Gyldmark, et al.
Epidemiology and Infection|May 16, 2012
Dose-specific efficacy of Haemophilus influenzae type b conjugate vaccines: a systematic review and meta-analysis of controlled clinical trialsU K Griffiths, A Clark, B Gessner, et al.
Tropical Medicine & International Health : TM & IH|October 8, 2016
Household experience and costs of seeking measles vaccination in rural Guinea-BissauS Byberg, A B Fisker, A Rodrigues, et al.
Vaccine|January 18, 2006
Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian FederationA E Platonov, U K Griffiths, M V Voeykova, et al.
Human Vaccines & Immunotherapeutics|May 10, 2016
The value of demonstration projects for new interventions: The case of human papillomavirus vaccine introduction in low- and middle-income countriesN Howard, S Mounier-Jack, K E Gallagher, et al.
Vaccine|December 4, 2022
Sustainable financing for Immunization Agenda 2030H Saxenian, S Alkenbrack, M Freitas Attaran, et al.
Vaccine|July 28, 2010
Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experienceR A Hajjeh, L Privor-Dumm, K Edmond, et al.
Pageof 2